As a part of the Medicare Quality Payment Program: (QPP), reimbursement now depends on pay-for-performance quality measures, with the percentage of Medicare payments -incentives and penalties -being dependent on performance, and increasing in size annually. The intent of this project was to expand the learning of quality metrics within the academic setting into the systemic approach found in the Department of Defense.
Case Description:
A young adult patient presented to the PCP with the complaint of a new palpable midline neck mass that the patient noted when resting his/her chin on hands. Ultrasound and CT of the neck showed a heterogenous ill-defined mass that abutted the hyoid bone. At that time, the patient was sent to an otolaryngologist who performed an FNA that showed atypical cells. The patient underwent excision of the thyroglossal duct cyst via the Sistrunk Procedure. The pathologic evaluation showed a thyroglossal duct cyst and a 3.1cm papillary thyroid carcinoma. The patient then underwent a total thyroidectomy, which revealed a co-existing papillary thyroid microcarcinoma (3mm). The patient then underwent radioactive iodine treatment.
Discussion: Papillary thyroid carcinoma in a thyroglossal duct cyst is an uncommon malignancy. It is important to be aware of this possibility in thyroglossal duct cysts.
Surgical removal is recommended for definitive diagnosis and treatment of the thyroglossal duct cyst. When papillary thyroid carcinoma is preset, then definitive treatment includes total thyroidectomy and radioactive iodine given the risk of cervical lymph node metastasis.  https://doi.org/10.32873/unmc.dc.gmerj.1.1.064
